Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

ScinoPharm Taiwan Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Scinopharm Taiwan Limited (1789) - Financial Analysis Review

Scinopharm Taiwan Limited (1789) - Financial Analysis Review Summary ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmaceutical...

12 Feb 2016 GlobalData 44 $300.00

Thomson Reuters Stock Report - ScinoPharm Taiwan Ltd (1789-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

12 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Scinopharm Taiwan Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Feb 2016 Wright Reports 55 $75.00

Scinopharm Taiwan Limited (1789) - Financial Analysis Review

Scinopharm Taiwan Limited (1789) - Financial Analysis Review Summary ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmaceutical...

15 Dec 2015 GlobalData 45 $300.00

Is Scinopharm Taiwan Limited Share Price Sustainable?

23 Nov 2015 Sadif Analytics Prime 12 $25.00

ScinoPharm Taiwan (1789 TT): Rebound from a Trough

We see Chinese API companies gradually losing its price competitiveness due to tightened environment regulations and rising l...

16 Nov 2015 MasterLink Securities Corporation 6 $58.00

神隆 (1789) :谷底已過,營運將逐步回升

元富觀察,中國原料藥產業受到環保規範及人力成本增加,價格優勢逐漸消失,印度品質則不穩定,陸續被發警告信,在產業趨向良性競爭的態勢下,2015年神隆客戶已逐漸回籠,且神隆新藥代工已有9項處於臨床三期試驗,近年亦向下游整合自送困難學名藥,並跨足針劑製劑,...

10 Nov 2015 MasterLink Securities Corporation 5 $35.00

神隆(1789.TT)營運谷底過,惟評價仍不低,維持中立

營運谷底過,惟評價仍不低,維持中立:預估神隆2015年營收41.4億元(+0.9%YoY),毛利率40.3%,稅後淨利6.73億元(+39.1%YoY),稅後EPS 0.92元,2016年營收46.6億元(+12.8%YoY),毛利率41.2%,稅後...

10 Nov 2015 SinoPac Sec Investment Service Traditional Chinese 4 $23.00

Scinopharm Taiwan Limited (1789) - Financial Analysis Review

Scinopharm Taiwan Limited (1789) - Financial Analysis Review Summary ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmaceutical...

22 Sep 2015 GlobalData 33 $125.00